Cataract Surgery on Advanced Age Related Macular Degeneration Patients
NCT ID: NCT04045704
Last Updated: 2021-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-10-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients
NCT04074954
Posterior Capsulotomy in Cataract Complicated With Primary Posterior Capsule Opacification.
NCT03701139
Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract
NCT04014699
Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification
NCT02445274
Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts
NCT02581046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cataract Surgery
Patients with bilateral Advanced Age-related macular degeneration and concurrent cataracts will be receiving bilateral cataract surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patients who chose to have bilateral cataract surgery, were able to understand the research parameters, and had no other severe eye disease that may distort the studies results.
Patients will be selected for the study according to the National Eye Institute definition of Advanced AMD.
"Advanced AMD (AREDS category 4) is characterized by one or more of the following (in the absence of other causes) in one eye:
Geographic atrophy of the RPE involving the foveal center.
Neovascular maculopathy that includes the following:
* Choroidal neovascularization (CNV) defined as pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane
* Serous and/or hemorrhagic detachment of the neurosensory retina or RPE
* Retinal hard exudates (a secondary phenomenon resulting from chronic intravascular leakage)
* Subretinal and sub-RPE fibrovascular proliferation
* Disciform scar (subretinal fibrosis)"
Exclusion Criteria
* Inability to complete the required testing (auto-refractive and visual acuity)
* Inability to attend appointments
* Inability to complete the questionnaire with Co-I assistance
* Severe eye disease that may distort the studies results such as but not limited to Epithelial Basement Membrane Dystrophy (EBMD) and retinal detachments.
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeffrey Chambers
Clinical Assistant Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H19-00830
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.